ABL Diagnostics Société anonyme (EPA:ABLD)
France
· Delayed Price · Currency is EUR 5.50
0.00 (0.00%)
At close: May 12, 2025, 5:30 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €88.63 million as of May 12, 2025. Its market cap has increased by 79.74% in one year.
Market Cap
88.63M
Enterprise Value
90.65M
Revenue
6.22M
Ranking
n/a
PE Ratio
310.78
Stock Price
€5.50
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 88.63M, an increase of 3,433.61%. That is a compound annual growth rate of 15.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 88.63M | 123.58% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | 2.96M | -59.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 113.18B |
| EssilorLuxottica Société anonyme | 110.66B |
| Sartorius Stedim Biotech | 19.70B |
| bioMérieux | 13.72B |
| Eurofins Scientific SE | 10.20B |
| Ipsen | 8.41B |
| Virbac | 2.56B |
| emeis Société anonyme | 1.77B |